Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 G-CSF: status quo and new indications.

× No keyword cloud information.

63 in total

1. Recombinant human granulocyte colony-stimulating factor induces granulocytosis in vivo.

Authors: M Fujisawa; Y Kobayashi; T Okabe; F Takaku; Y Komatsu; S Itoh
Journal: Jpn J Cancer Res Date: 1986-09

2. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

Authors: K M Taylor; S Jagannath; G Spitzer; J A Spinolo; S L Tucker; B Fogel; F F Cabanillas; F B Hagemeister; L M Souza
Journal: J Clin Oncol Date: 1989-12 Impact factor: 44.544

3. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.

Authors: J Neidhart; A Mangalik; W Kohler; C Stidley; J Saiki; P Duncan; L Souza; M Downing
Journal: J Clin Oncol Date: 1989-11 Impact factor: 44.544

4. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy.

Authors: A Lindemann; F Herrmann; W Oster; G Haffner; W Meyenburg; L M Souza; R Mertelsmann
Journal: Blood Date: 1989-12 Impact factor: 22.113

5. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.

Authors: K Eguchi; S Sasaki; T Tamura; Y Sasaki; T Shinkai; K Yamada; Y Soejima; M Fukuda; Y Fujihara; H Kunitou
Journal: Cancer Res Date: 1989-09-15 Impact factor: 12.701

6. Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.

Authors: N Kubota; T Orita; K Hattori; M Oh-eda; N Ochi; T Yamazaki
Journal: J Biochem Date: 1990-03 Impact factor: 3.387

Review 7. The use of myeloid hematopoietic growth factors in patients with HIV infection.

Authors: R T Mitsuyasu; S A Miles; D W Golde
Journal: Int J Cell Cloning Date: 1990-01

8. [A double-blind, cross-over clinical trial of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].

Authors: A Oyama; K Ota; S Asano; F Takaku; Y Yoshida; Y Uzuka; M Omine; S Furusawa; O Takatani; U Sawada
Journal: Nihon Gan Chiryo Gakkai Shi Date: 1990-10-20

9. The effect of recombinant human colony-stimulating factors on hematopoietic reconstitution following autologous bone marrow transplantation.

Authors: W P Peters
Journal: Semin Hematol Date: 1989-04 Impact factor: 3.851

10. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

Authors: M H Bronchud; A Howell; D Crowther; P Hopwood; L Souza; T M Dexter
Journal: Br J Cancer Date: 1989-07 Impact factor: 7.640

2 in total

1. Marker gene transfer into leukapheresis preparations containing hematopoietic progenitor cells: application in high-dose therapy rescued by reinfusion of peripheral blood hematopoietic progenitors in patients with multiple myeloma.

Authors: F Herrmann; M Kiehntopf; M A Brach; D Carstanjen; C von Schilling
Journal: J Mol Med (Berl) Date: 1995-04 Impact factor: 4.599

2. Granulocyte-macrophage colony-stimulating factor (GM-CSF): a variety of possible applications in clinical medicine.

Authors: M Weiss; B H Belohradsky
Journal: Infection Date: 1992 Impact factor: 3.553

2 in total